STRUCTURAL AND MOLECULAR ADAPTATIONS TO DEXAMETHASONE AND UNACYLATED GHRELIN ADMINISTRATION IN SKELETAL MUSCLE OF THE MICE

被引:9
作者
Canepari, M. [1 ,2 ]
Agoni, V [1 ,2 ]
Brocca, L. [1 ,2 ]
Ghigo, E. [3 ]
Gnesi, M. [7 ]
Minetto, M. A. [3 ,4 ]
Bottinelli, R. [1 ,2 ,5 ,6 ]
机构
[1] Univ Pavia, Dept Mol Med, Via Forlanini 6, I-27100 Pavia, Italy
[2] Univ Pavia, Interuniv Inst Myol, Pavia, Italy
[3] Univ Turin, Dept Med Sci, Div Endocrinol & Metab, Turin, Italy
[4] Univ Turin, Dept Surg Sci, Div Phys Med & Rehabil, Turin, Italy
[5] Univ Pavia, Sci Inst Pavia, Fdn Salvatore Maugeri IRCCS, Pavia, Italy
[6] Univ Pavia, Interdept Ctr Biol & Sport Med, Pavia, Italy
[7] Univ Pavia, Sect Biostat & Clin Epidemiol, Dept Publ Hlth Expt & Forens Med, Pavia, Italy
来源
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2018年 / 69卷 / 02期
关键词
glucocorticoids; dexamethasone; steroid myopathy; unacylated ghrelin; muscle atrophy; 1 NULL MICE; MITOCHONDRIAL DYSFUNCTION; GLUCOCORTICOID-RECEPTOR; UP-REGULATION; ATROPHY; EXPRESSION; UBIQUITIN; MECHANISMS; ATROGIN-1; PROTEINS;
D O I
10.26402/jpp.2018.2.14
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The central goal of this study was to identify the primary mechanisms triggering steroid atrophy. Adaptations of soleus (Sol) and vastus lateralis (VL) muscles of C57BL/6 female mice were studied following 3, 7 and 15 days of daily intraperitoneal injection (5 mg kg(-1) day(-1)) of dexamethasone (DEX) (chronic treatment) and 1, 3 and 10 hours after a single DEX injection (acute treatment). In the chronic treatment, analyses were performed 24 hours after the last injection. Gene expression of major components of the intracellular signalling pathways controlling mass and metabolism were assessed. Analyses were repeated following DEX and unacylated ghrelin (UAG) (100 mu g kg(-1)day(-1)), co-administration. We found a significant VL fibres atrophy after 7 (13%) and 15 (28%) days and a Sol fibres atrophy (23%) after 15 days of DEX treatment. The acute treatment showed, in both muscles, several responses in most signalling pathways, among which the enhanced gene expression of Murf-1 (6-fold change in VL and 3-fold in Sol) and myostatin (6-fold change in VL and 20-fold in Sol). In Sol, UAG administration was able to fully counteract muscle atrophy and Murf-1 upregulation, but not the upregulation of myostatin, suggesting a causal relationship between muscle atrophy and Murf-1. Results indicate that: a) the primary mechanism triggering steroid atrophy is an early transient activation of Murf-1; b) UAG inhibits Murf-1 induction counteracting steroid atrophy. The present work contributes to the understanding of the complexity of the muscle response to glucocorticoids.
引用
收藏
页码:283 / 296
页数:14
相关论文
共 51 条
  • [31] A treadmill ramp protocol using simultaneous changes in speed and grade
    Porszasz, J
    Casaburi, R
    Somfay, A
    Woodhouse, LJ
    Whipp, BJ
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (09) : 1596 - 1603
  • [32] The mitochondrion as a primary site of action of steroid and thyroid hormones: Presence and action of steroid and thyroid hormone receptors in mitochondria of animal cells
    Psarra, AMG
    Solakidi, S
    Sekeris, CE
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 246 (1-2) : 21 - 33
  • [33] Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity
    Qin, Jian
    Du, Rong
    Yang, Ya-Qun
    Zhang, Hong-Qiang
    Li, Qing
    Liu, Lin
    Guan, Hong
    Hou, Jian
    An, Xiao-Rong
    [J]. RESEARCH IN VETERINARY SCIENCE, 2013, 94 (01) : 84 - 89
  • [34] Acylated and unacylated ghrelin administration to blunt muscle wasting
    Reano, Simone
    Graziani, Andrea
    Filigheddu, Nicoletta
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (03) : 236 - 240
  • [35] Glucocorticoid-induced myopathy
    Rodrigues Pereira, Rosa Maria
    de Carvalho, Jozelio Freire
    [J]. JOINT BONE SPINE, 2011, 78 (01) : 41 - 44
  • [36] The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression
    Salehian, Behrouz
    Mahabadi, Vahid
    Bilas, Josephine
    Taylor, Wayne E.
    Ma, Kun
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (09): : 1239 - 1247
  • [37] Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
    Sandri, M
    Sandri, C
    Gilbert, A
    Skurk, C
    Calabria, E
    Picard, A
    Walsh, K
    Schiaffino, S
    Lecker, SH
    Goldberg, AL
    [J]. CELL, 2004, 117 (03) : 399 - 412
  • [38] Smad2 and 3 transcription factors control muscle mass in adulthood
    Sartori, Roberta
    Milan, Giulia
    Patron, Maria
    Mammucari, Cristina
    Blaauw, Bert
    Abraham, Reimar
    Sandri, Marco
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 296 (06): : C1248 - C1257
  • [39] Mechanisms of glucocorticoid-induced myopathy
    Schakman, O.
    Gilson, H.
    Thissen, J. P.
    [J]. JOURNAL OF ENDOCRINOLOGY, 2008, 197 (01) : 1 - 10
  • [40] Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats
    Schakman, O
    Gilson, H
    de Coninck, V
    Lause, P
    Verniers, J
    Havaux, X
    Ketelslegers, JM
    Thissen, JP
    [J]. ENDOCRINOLOGY, 2005, 146 (04) : 1789 - 1797